NIAID – first guidelines for food allergy management | Nurse Story
Links shared publicly online about this topic.
- 615total visits
NIAID – first guidelines for food allergy management | Nurse Story
View full resource at nursestory.com
Tags: Allergies, Food Allergy, Nursing Professions, Nurse, Nursing
Most Recently Shared on December 31, 2010 at 4:11 pm By:
staggering number of ER visits for food allergies http://reut.rs/gMmrKo makes the new NIAID guidelines more pertinent http://bit.ly/dJqFEo
GenVec receives NIAID’s Phase I SBIR grant to support RSV vaccine program
news-medical.net — “GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's Respiratory Syncytial Virus (RSV) vaccine program.” View full resource at news-medical.net
Most Recently Shared on May 4, 2012 at 6:13 am By:
GenVec receives NIAID’s Phase I SBIR grant to support RSV vaccine program: GenVec, Inc. announced today that it ... http://t.co/jltN39Bf
A Study of Severe Viral Infections in Non-immunocompromised Patients
niaid.nih.gov — “A Study of Severe Viral Infections in Non-immunocompromised Patients” View full resource at niaid.nih.gov
Most Recently Shared on March 29, 2012 at 5:00 pm By:
Medscape Pediatrics Health Site and Pediatrics
#NIAID is seeking patients with unusually severe viral infections and normal immune system for new study http://t.co/DRjzm9gr
Emergent receives NIAID grant to advance development of MVA85A TB vaccine
news-medical.net — “Emergent BioSolutions Inc. today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to advance the development of MVA85A, a candidate vaccine against tuberculosis.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 10:56 am By:
News-Medical.Net Health News and Oncology
Oncology News: Emergent receives NIAID grant to advance development of MVA85A TB vaccine: Emergent BioSolutions ... http://t.co/UC1VKbHa
NIAID Statement on World TB Day - March 24, 2012, March 21, 2012 News Release - National Institutes of Health (NIH)
nih.gov — “The theme of World TB Day 2012, Eliminate TB in My Lifetime, boldly challenges us to improve and expand tuberculosis (TB) control and related research efforts that recently have led to slowly declining rates of illness and death from this ancient disease. Even with the technological advances available in the early part of the 21st century, the elimination of TB will be an enormous task. TB claimed 1.45 million lives worldwide in 2010, according to the World Health Organization. An estimated one-” View full resource at nih.gov
Most Recently Shared on March 21, 2012 at 6:46 pm By:
George Huba, Ph.D. Psychologist, PhD, and Doctor
NIAID Statement on World TB Day - March 24, 2012 - The theme of World TB Day 2012, Eliminate TB in My Lifetime, bold... http://t.co/mTFXmpvd
NIAID Statement on World TB Day - March 24, 2012, March 21, 2012 News Release - National Institutes of Health (NIH)
nih.gov — “The theme of World TB Day 2012, Eliminate TB in My Lifetime, boldly challenges us to improve and expand tuberculosis (TB) control and related research efforts that recently have led to slowly declining rates of illness and death from this ancient disease. Even with the technological advances available in the early part of the 21st century, the elimination of TB will be an enormous task. TB claimed 1.45 million lives worldwide in 2010, according to the World Health Organization. An estimated one-” View full resource at nih.gov
Most Recently Shared on March 21, 2012 at 3:49 pm By:
News: NIAID Statement on World TB Day - March 24, 2012 http://t.co/DAjlEu8f
Food Allergy Diagnosis | Food Allergies | ACAAI
acaai.org — “Food Allergy Diagnosis | Food Allergies | ACAAI” View full resource at acaai.org
Most Recently Shared on February 6, 2012 at 8:44 pm By:
Dr. Oz Anti-Allergy Diet testing error–NIAID Guidelines: DON’T use IgG blood tests for food allergy testing/diagnosis http://t.co/4osnQI8d
Chikungunya vaccine trial begins to enroll participants, December 20, 2011 News Release - National Institutes of Health (NIH)
nih.gov — “An experimental vaccine to prevent chikungunya fever, a viral disease spread by certain species of mosquitoes, is being tested in a clinical trial conducted by National Institute of Allergy and Infectious Diseases NIAID scientists at the National Institutes of Health.” View full resource at nih.gov
Most Recently Shared on December 20, 2011 at 8:54 pm By:
News: Chikungunya vaccine trial begins to enroll participants http://t.co/oce0hhlw
NIAID-Sponsored 2010 Guidelines for Managing Food Allergy: Applications in the Pediatric Population
pediatrics.aappublications.org — “NIAID-Sponsored 2010 Guidelines for Managing Food Allergy: Applications in the Pediatric Population” View full resource at pediatrics.aappublications.org
Most Recently Shared on November 2, 2011 at 1:14 am By:
Ves Dimov, M.D. Allergist, Physician, Doctor, and Internist
NIAID-Sponsored 2010 Guidelines for Managing Food Allergy: Applications in the Pediatric Population http://t.co/gSiAyWaC
NYUCN to study 'Combination HIV Prevention for Kenyan Youth'
news-medical.net — “New York University College of Nursing (NYUCN) received a four-year, $ 2.8M grant from the National Institute of Health's National Institute of Allergy and Infectious Diseases (NIH/NIAID) to study "Combination HIV Prevention for Kenyan Youth."” View full resource at news-medical.net
Most Recently Shared on October 29, 2011 at 6:58 am By:
Pregnancy News: NYUCN to study 'Combination HIV Prevention for Kenyan Youth': New York University College of Nur... http://t.co/FPS3iY8H
Unither Virology receives NIAID contract for glycobiology antiviral platform
news-medical.net — “United Therapeutics Corporation announced that its subsidiary, Unither Virology, LLC, has been awarded a contract for up to approximately $45 million under a Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for studies directed at the development of a broad-spectrum antiviral drug based on its glycobiology antiviral platform.” View full resource at news-medical.net
Most Recently Shared on October 10, 2011 at 12:55 pm By:
Unither Virology receives NIAID contract for glycobiology antiviral platform: United Therapeutics Corporation an... http://t.co/MtQxbVZP
Community Engagement in NIAID's HIV/AIDS Clinical Trials Networks - The Body
thebody.com — “Since early in the HIV/AIDS epidemic, the National Institute of Allergy and Infectious Diseases (NIAID) has involved community representatives and ...” View full resource at thebody.com
Most Recently Shared on October 7, 2011 at 2:01 pm By:
Community Engagement in NIAID's HIV/AIDS Clinical Trials Networks http://t.co/zISJgd4q #hiv #aids
NOT-AI-12-010: Announcement of a National Institute of Allergy and Infectious Diseases (NIAID) Town Hall Meeting and Webinar on the Future of the NIAID Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases (RCE) Program
grants1.nih.gov — “NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Announcement of a National Institute of Allergy and Infectious Diseases (NIAID) Town Hall Meeting and Webinar on the Future of the NIAID Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases (RCE) Program NOT-AI-12-010. NIAID” View full resource at grants1.nih.gov
Most Recently Shared on September 17, 2011 at 9:12 pm By:
NOT-AI-12-010: Announcement of a National Institute of Allergy and ... http://t.co/VfPfS8Ag
NIAID Funds New Consortia for AIDS Vaccine Research - The Body
thebody.com — “The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded a total of approximately $12 ...” View full resource at thebody.com
Most Recently Shared on September 5, 2011 at 6:00 pm By:
NIAID Funds New Consortia for AIDS Vaccine Research http://t.co/T6iKAKF #hiv #prevention
Virus-Like Particle Vaccine Protects Monkeys from Chikungunya Virus | Highlight HEALTH
highlighthealth.com — “An experimental vaccine developed using non-infectious virus-like particles (VLP) has protected macaques and mice against chikungunya virus, a mosquito-borne pathogen that has infected millions of people in Africa and Asia and causes debilitating pain, researchers at the National Institutes of Health have found. Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) developed the vaccine because there is no vaccine or treatment for chikungunya virus infection.” View full resource at highlighthealth.com
Most Recently Shared on September 3, 2011 at 12:00 pm By:
Walter Jessen - Highlight HEALTH Health Executive and Health Organization
Virus-Like Particle Vaccine Protects Monkeys from Chikungunya Virus | Highlight HEALTH - http://ow.ly/6d8V4
"Drugs That Fight HIV" Poster Features Images of Antiretroviral Medications - The Body
thebody.com — “To help clinicians and patients better identify the many medications available to treat HIV infection, NIAID recently published a poster titled 'Drugs ...” View full resource at thebody.com
Most Recently Shared on August 30, 2011 at 5:00 pm By:
"Drugs That Fight HIV" Poster Features Images of Antiretroviral Medications http://t.co/jcs9qIJ #aids #medications #antiretrovirals
Advertisement
